2,6-dimethyl-4-(2'-nitrosophenyl)-3,5-pyridinedicarboxylic acid dimethyl ester: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 128034 |
| SCHEMBL ID | 744281 |
| MeSH ID | M0180848 |
| Synonym |
|---|
| 50428-14-3 |
| dnpdc |
| FT-0665631 |
| dimethyl 2,6-dimethyl-4-(2-nitrosophenyl)pyridine-3,5-dicarboxylate |
| 2,6-dimethyl-4-(2'-nitrosophenyl)-3,5-pyridinedicarboxylic acid dimethyl ester |
| 3,5-pyridinedicarboxylic acid, 2,6-dimethyl-4-(2-nitrosophenyl)-, dimethyl ester |
| unii-23n9nly17f |
| nitrosonifedipine |
| 23n9nly17f , |
| 2,6-ntp |
| dehydronitroso nifedipine |
| SCHEMBL744281 |
| STL450974 |
| DTXSID50198466 |
| nifedipine impurity b, european pharmacopoeia (ep) reference standard |
| nifedipine imp. b (ep); nifedipine nitrosophenylpyridine analog; dimethyl 2,6-dimethyl-4-(2-nitrosophenyl)pyridine-3,5-dicarboxylate; nitrosophenylpyridine analogue of nifedipine; nifedipine impurity b |
| 2,6-dimethyl-3,5-dimethoxycarbonyl-4-(2-nitrosophenyl)pyridine |
| F19299 |
| nifedipine major degradant |
| nifedipine impurity b [ep impurity] |
| 3,5-pyridinedicarboxylic acid, 2,6-dimethyl-4-(2-nitrosophenyl)-, 3,5-dimethyl ester |
| dehydronitrosonifedipine |
| nifedipine impurity b |
| dimethyl-2,6-dimethyl-4-(2-nitrosophenyl) pyridine-3,5-dicarboxylate |
| A899730 |
| AS-82953 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 2 (18.18%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (81.82%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Article | Year |
|---|---|
| Drug discovery for overcoming chronic kidney disease (CKD): development of drugs on endothelial cell protection for overcoming CKD. Journal of pharmacological sciences, Volume: 109, Issue: 1 | 2009 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |